Enabled interferon signaling evasion in an immune-competent transgenic mouse model of parainfluenza virus 5 infection

Thomas A Kraus1, Lily Garza, Curt M Horvath

  • 1Department of Medicine, Northwestern University, Evanston, IL 60208, USA. t-kraus@northwestern.edu

Virology
|October 30, 2007
PubMed

Insights

Transgenic mice expressing human STAT2 enable Parainfluenza virus 5 (PIV5) to degrade STAT1, enhancing viral replication. This model aids studying paramyxovirus pathogenesis and innate immune evasion.

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Parainfluenza virus 5 (PIV5) infects many mammals but replicates poorly in mice.
  • PIV5 evades human interferon (IFN) signaling by degrading STAT1 via a STAT2-dependent pathway.
  • Murine STAT2 does not support STAT1 degradation, contributing to species-specific PIV5 replication restriction.

Purpose of the Study:

  • To investigate the role of STAT2 in PIV5 species restriction.
  • To develop a mouse model for studying PIV5 pathogenesis and innate immune evasion.

Main Methods:

  • Generation of transgenic mice ubiquitously expressing human STAT2.
  • Infection of transgenic and wild-type mice with PIV5.
  • Analysis of STAT1 degradation, viral replication, and viral load in lung tissue.

Main Results:

  • PIV5 infection induced STAT1 degradation in cells from human STAT2 transgenic mice.
  • Transgenic mice exhibited enhanced PIV5 replication and protein expression compared to non-transgenic littermates.
  • Intranasal PIV5 inoculation led to increased viral load in the lungs of transgenic mice.

Conclusions:

  • Human STAT2 expression in mice overcomes PIV5 species restriction by enabling STAT1 degradation.
  • These transgenic mice serve as a valuable model for studying paramyxovirus innate immune evasion and pathogenesis.